Suchergebnisse - "Lu, Yong-Chen"

PubPharm (17)

1

TREM-2 mediates dendritic cell–induced NO to suppress Th17 activation and ameliorate chronic kidney diseases

enthalten in: Journal of molecular medicine | 2022

von Lin, C. | Chang, T. | Lu, Y. | +11

2

Isolation and Characterization of an HLA-DPB104: 01-restricted MAGE-A3 T-Cell Receptor for Cancer Immunotherapy

enthalten in: Journal of immunotherapy | 2016

von Yao, X. | Lu, Y. | Parker, L. | +8

3

Targeting neoantigens for cancer immunotherapy

enthalten in: International immunology | 2016

von Lu, Y. | Robbins, P.

4

Targeting neoantigens for cancer immunotherapy: Table 1

enthalten in: International immunology | 2016

von Lu, Y. | Robbins, P.

5

T-Cell transfer therapy targeting mutant KRAS in cancer.(Case study)

enthalten in: The New England journal of medicine | 2016

von Rosenberg, S. | Jia, L. | Groh, E. | +9

6

The hepatitis B virus e antigen suppresses the respiratory burst and mobility of human monocytes and neutrophils

enthalten in: Immunobiology | 2014

von Leu, C. | Lu, Y. | Peng, W. | +2

7

Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions

enthalten in: Clinical cancer research | 2014

von Lu, Y. | Yao, X. | Crystal, J. | +9

8

Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer

enthalten in: Science | 2014

von Tran, E. | Turcotte, S. | Gros, A. | +10

9

Mutated PPP1R3B Is Recognized by T Cells Used To Treat a Melanoma Patient Who Experienced a Durable Complete Tumor Regression

enthalten in: The journal of immunology | 2013

von Lu, Y. | Yao, X. | Li, Y. | +8

10

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

enthalten in: Nature medicine | 2013

von Robbins, P. | Lu, Y. | El-Gamil, M. | +9